The convergent procedure versus catheter ablation alone in longstanding persistent atrial fibrillation: A single centre, propensity-matched cohort study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 03 2020
Historique:
received: 29 08 2019
revised: 15 10 2019
accepted: 31 10 2019
entrez: 18 2 2020
pubmed: 18 2 2020
medline: 14 1 2021
Statut: ppublish

Résumé

Maintenance of sinus rhythm is challenging in patients with longstanding persistent atrial fibrillation (PeAF). Minimally invasive surgical AF ablation may improve outcomes when combined with catheter ablation (the 'convergent' procedure). This study evaluates the safety and efficacy of the convergent procedure versus catheter ablation alone in longstanding PeAF. 43 consecutive patients with longstanding PeAF underwent subxiphoid endoscopic ablation of the posterior left atrium followed by catheter ablation from 2013 to 2018. The primary outcome was AF-free survival at 12 months; secondary outcomes included change in EHRA class, echocardiographic data, procedural complications, freedom from anti-arrhythmic drugs (AADs), and long term arrhythmia-free survival. Outcomes were compared with a matched group of 43 patients who underwent catheter ablation alone. Both groups underwent multiple catheter ablations as required. Baseline characteristics were similar between groups. After 12 months, the convergent procedure was associated with increased AF-free survival on AADs (60.5% versus 25.6%, p = .002) and off AADs (37.2% versus 13.9%, p = .025), versus catheter ablation. Allowing for multiple procedures, after 30.5 ± 13.3 months' follow-up the convergent procedure was associated with increased arrhythmia-free survival on AADs (58.1% versus 30.2%, p = .016) and off AADs (32.5% versus 11.6%, p = .036) versus catheter ablation. There were more complications in the convergent procedure group (11.6% versus 2.3%, p = .2). Multivariate analysis identified only the convergent procedure (OR 3.06 (1.23-7.6), p = .017) as predictive of arrhythmia-free survival long term. In longstanding PeAF, the convergent procedure is associated with improved arrhythmia-free survival versus catheter ablation alone. Complication rates are significant but have been shown to depreciate with experience.

Sections du résumé

BACKGROUND
Maintenance of sinus rhythm is challenging in patients with longstanding persistent atrial fibrillation (PeAF). Minimally invasive surgical AF ablation may improve outcomes when combined with catheter ablation (the 'convergent' procedure). This study evaluates the safety and efficacy of the convergent procedure versus catheter ablation alone in longstanding PeAF.
METHODS
43 consecutive patients with longstanding PeAF underwent subxiphoid endoscopic ablation of the posterior left atrium followed by catheter ablation from 2013 to 2018. The primary outcome was AF-free survival at 12 months; secondary outcomes included change in EHRA class, echocardiographic data, procedural complications, freedom from anti-arrhythmic drugs (AADs), and long term arrhythmia-free survival. Outcomes were compared with a matched group of 43 patients who underwent catheter ablation alone. Both groups underwent multiple catheter ablations as required. Baseline characteristics were similar between groups.
RESULTS
After 12 months, the convergent procedure was associated with increased AF-free survival on AADs (60.5% versus 25.6%, p = .002) and off AADs (37.2% versus 13.9%, p = .025), versus catheter ablation. Allowing for multiple procedures, after 30.5 ± 13.3 months' follow-up the convergent procedure was associated with increased arrhythmia-free survival on AADs (58.1% versus 30.2%, p = .016) and off AADs (32.5% versus 11.6%, p = .036) versus catheter ablation. There were more complications in the convergent procedure group (11.6% versus 2.3%, p = .2). Multivariate analysis identified only the convergent procedure (OR 3.06 (1.23-7.6), p = .017) as predictive of arrhythmia-free survival long term.
CONCLUSIONS
In longstanding PeAF, the convergent procedure is associated with improved arrhythmia-free survival versus catheter ablation alone. Complication rates are significant but have been shown to depreciate with experience.

Identifiants

pubmed: 32063280
pii: S0167-5273(19)34337-2
doi: 10.1016/j.ijcard.2019.10.053
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-53

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. Ahsan has received an educational grant and speaker fees from Atricure.

Auteurs

E Maclean (E)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK; William Harvey Research Institute, Charterhouse Square, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

J Yap (J)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

B Saberwal (B)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

S Kolvekar (S)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

W Lim (W)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

N Wijesuriya (N)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

N Papageorgiou (N)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

G Dhillon (G)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

R J Hunter (RJ)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK; William Harvey Research Institute, Charterhouse Square, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

M Lowe (M)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

P Lambiase (P)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

A Chow (A)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

H Abbas (H)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

R Schilling (R)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK; William Harvey Research Institute, Charterhouse Square, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

E Rowland (E)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK.

S Ahsan (S)

Barts Heart Centre, St Bartholomew's Hospital, W Smithfield, London EC1A 7BE, UK. Electronic address: syedahsan@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH